CAPITAL PRO-ÉGAUX INC., THROUGH ITS WHOLLY OWNED SUBSIDIARY TECHNIQUE
D'USINAGE SINLAB INC, HAS RECEIVED COURT ACTIONS FILED BY NOBEL BIOCARE IN
GERMANY AND ITALY

LACHENAIE, QC, Aug. 26 /CNW Telbec/ - Capital Pro-Égaux Inc. (the "Company") reports that it's wholly owned subsidiary Technique d'usinage Sinlab Inc., has received translated court actions from Nobel Biocare to attempt to nullify the company German and Italian superstructure patent1,043,960 issued September 3^rd of 2003.

These procedures are filed by Nobel Biocare subsequently to a COURT ACTION   filed on June 25^th, 2010 by Technique d'usinage Sinlab Inc against BioCad Medical Inc, a Québec city based company wholly owned by Nobel Biocare, for patent infringement of the Company Canadian patent 2,575,964 issued on 27th of May 2008.

About Pro-Égaux Inc.

Pro-Égaux through its wholly owned subsidiary, Technique d'usinage Sinlab Inc., is a company based in Lachenaie, Quebec, specializing mainly in the conception and design of titanium products to be used in the dental prosthesis restoration industry.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

For further information: